New Delhi, Jan 18 (IANS) A team of US scientists has uncovered how a molecule found on certain bacteria may drive blood clotting in sepsis — a life-threatening condition that causes about eight million deaths per year.
The team at Oregon Health & Science University (OHSU) focused on the role of specific blood clotting mechanisms in sepsis.
The findings may pave the way for enhancing treatments for critically ill patients. They found that lipopolysaccharide, or LPS — a molecule found on the surface of certain bacteria like E. coli — can directly activate proteins in the blood that trigger clotting.
This process can both block blood flow and damage vital organs in a chain reaction where proteins in the blood work together to form clots. The researchers found a specific type of LPS, called O26:B6, that is particularly good at setting off this reaction, making it more likely to cause clotting problems.
The research, published in the Journal of Biological Chemistry, is based on a study conducted in nonhuman primates. The team found that when bacteria containing LPS entered the bloodstream, it quickly activated the clotting system.
This included coagulating proteins like factor XII, which seems to initiate the clotting process, causing a chain reaction. “People who are born without factor XII are healthy and don’t bleed abnormally,” said Joseph Shatzel, a physician-scientist at OHSU.
“That makes it a great target for therapies — blocking it might help stop dangerous clots without causing bleeding.”
Andre L. Lira, Postdoctoral scholar and lead author of the study, said his research focuses on how the physical properties of bacterial surfaces trigger the clotting system. Sepsis can arise from bacterial, viral, or fungal infections.
“Even when we know the bacteria causing the infection, different strains can behave differently,” he said. “By understanding this, we hope to develop precision therapies.” The team is working on experimental treatments targeting factor XII, including antibodies designed to block its activity.
–IANS
rvt/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
